The latest edition of the Atlas of MS shows there are 2.8 million people living with multiple sclerosis around the world.

The Atlas of MS is a powerful advocacy tool for MS organisations and advocates to drive policy changes that can remove obstacles for people with MS and their families in their country. The data is a key way of shining a spotlight on MS to increase awareness and understanding around the world.

Malaysia

Key statistics and data collected from MSIF's Atlas of MS

Who is affected?

Who is affected?

29

years is the average age of an MS diagnosis.

Women with MS

83%

of people with MS are women.

Number of people with MS?

Number of people with MS

913

people are living with MS. This equates to 1 in every 35,000 people.

Children with MS

182

children under the age of 18 are
living with MS.

Diagnosis of MS?

Diagnosis of MS

176

new people are diagnosed each year. That's 15 diagnosed every month.

Diagnosed with MS

90%

of people are initially diagnosed with relapsing-remitting MS. 10% have progressive MS.

What is the Atlas of MS?

The Atlas of MS is the most extensive worldwide study of the epidemiology of MS and the global availability and accessibility of resources for people with MS.

Learn more

2020 worldwide study

The data shows that the number of people with MS across the globe has increased from 2.3 million in 2013 to 2.8 million in 2020. Download the report for the findings or download the full dataset if you would like to conduct your own analysis comparing multiple countries.

Powerful tool for change

The information in the Atlas of MS can be a powerful advocacy tool, shining a spotlight on MS and raising awareness of the lack of adequate resources available to diagnose, inform, treat, rehabilitate and support people with MS worldwide.

Find out how

With thanks to…

Worldwide collaboration

The Atlas of MS relies on data supplied by MS organisations from around the world. We are most grateful to the country coordinators and their colleagues for taking the time and effort to gather the information and data.

See contributor list

Clinical management of MS

The previous Atlas highlighted the inequalities in accessing treatments and care across the world. This new edition aimed to gather more data and covers the barriers to diagnosis, the availability of disease modifying treatments (DMTs) and how access varies globally. Additionally it covers healthcare provision (number of healthcare professionals, and the use of national guidelines or standards in relation to MS).

Sign up to stay informed when new data is available.